Great customer Service, wonderful products and easy to navigate website Great product, just wish it wasnt so expensive This is amazing
Alongside breaking down existing fat, AOD9604 also suppresses fatty acid synthesis, limiting new fat formation
Molecular Characteristics Compound Name: 5-Amino-1MQ CAS Number: 42464-96-0 Compound Class: Quinoline derivative small molecule Form: Encapsulated research compound Purity: 99% analytical purity Unit Size: 50mg capsules (60 count) Stability Profile and Storage Recommendations Store in a cool, dry environment Protect capsules from moisture and light Avoid excessive heat exposure Maintain sealed packaging when not in use Follow standard laboratory storage practices Solubility and Preparation Considerations Capsule contents may be dissolved in compatible laboratory solvents Suitable for biochemical assay buffer systems Compatible with aqueous laboratory solutions May be used in metabolic pathway assay preparations Compatible with standard in-vitro research protocols Technical Specifications product Name 5-Amino-1MQ 50mg Capsules brand BioPeptides cas 42464-96-0 purity 99% analytical purity unit Size 50mg capsules (60 count) form Encapsulated research compound synthesis Controlled chemical synthesis analytical HPLC and purity verification molecular Structure Quinoline-based small molecule stability Stable when stored in dry conditions Analytical Validation and Quality Assurance Purity verification using analytical testing Compound identity confirmation Batch-to-batch consistency evaluation Chemical stability verification Manufacturing quality control procedures Regulatory and Compliance Statement 5-Amino-1MQ supplied by BioPeptides is intended strictly for laboratory and scientific research use only
Every peptide, every vial, every timeprecision you can trust, prices you can count on, and service that stands out
We will discuss the benefits as well as the procedure for B12 shots and IV vitamin therapy treatments
Patients with Normal Intestinal Absorption Where the oral route is not deemed adequate, initial treatment similar to that for patients with pernicious anemia may be indicated depending on the severity of the deficiency
